A review of the anti‐inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose‐lowering activity. Here we review the latest evidence on the anti‐inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hattori, Y., Jojima, T., Tomizawa, A., Satoh, H., Hattori, S., Kasai, K., & Hayashi, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1831-8 · Cited by 183 · cited 1×
“…Marfella, & Paolisso, 2012; Satoh‐Asahara et al., 2013), whereas others have reported the potent anti‐inflammatory effects for GLP‐1 receptor agonists in both in vitro and in vivo studies (Cao et al., 2016; Hattori et al., 2010; Krasner, Ido, Ruderman, & Cacicedo, 2014; Shiraki et al., 2012).”
BackgroundRetractedPPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“…cell adhesion molecule‐1 (ICAM‐1), E‐selectin, nuclear factor kappa B (NF‐κb), hypoxia‐induced factor‐α, interleukin‐6 (IL‐6), MCP‐1, and TNF‐α (Aljada et al., 2006; Dandona, Chaudhuri, Ghanim, & Mohanty, 2007; Dhindsa et al., 2004; Esposito et al., 2002; Sun et al., 2014).”
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010 · cited 1×
“…detrimental impact of the chronic activation of the inflammation cascade on atherosclerosis‐mediated events that may also increase these events in diabetic patients (Magee, Grieve, Watson, & Brazil, 2017; Mannarino & Pirro, 2008; Marchesi et al., 2003; Pirro et al., 2004; Ridker et al., 2009).”
BackgroundGlyburide inhibits the Cryopyrin/Nalp3 inflammasome
Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P., Hoffman, H. M., & Dixit, V. M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903124 · Cited by 820 · cited 1×
“Lamkanfi et al. (2009) and Hill et al. (2017) showed that sulfonylureas can suppress NLRP3 inflammasome expression and prevent the inflammatory response.”
BackgroundMetabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710
Anti-inflammatory effects of metformin irrespective of diabetes status
Cameron, A. R., Morrison, V. L., Levin, D., Mohan, M., Forteath, C., Beall, C., McNeilly, A. D., Balfour, D. J. K., Savinko, T., Wong, A. K. F., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308445 · Cited by 704
Control of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531 · cited 2×
“2005) by preventing macrophage activation (Chawla, 2010) and reducing the expression/release of proinflammatory mediators such as C‐reactive protein (CRP), MMP‐9, plasminogen activator inhibitor‐ 1 (PAI‐1), IL‐1, and IL‐6 in both in vitro and in vivo studies (Consoli & Devangelio, 2005; Jiang, Ting, & Seed, 1998).”
BackgroundState of the art paper Sulfonylureas and their use in clinical practice
Sola, D., Rossi, L., Schianca, G. P. C., Maffioli, P., Bigliocca, M., Mella, R., Corlianò, F., Fra, G. P., Bartoli, E., & Derosa, G. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.53304 · Cited by 514
Cited by
Pattern recognition receptor‐mediated inflammation in diabetic vascular complications
Wang, X., Antony, V., Wang, Y., Wu, G., & Liang, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21711 · Cited by 73
“In addition, new therapies/agents developed against DAMPs, PRRs, and PRR‐associated downstream signaling molecules may effectively block the induction of diabetes.(64,67)”
BackgroundProtective effects of plant‐derived natural products on renal complications
Yaribeygi, H., Simental‐Mendía, L. E., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27950 · Cited by 46
Self-citationYaribeygi, H., Farrokhi, F. R., Abdalla, M. A., Sathyapalan, T., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6518221 · Cited by 31
“GLP-1RA is a class of newly introduced antidiabetic medications that are FDA approved in 2010 to manage patients with diabetes [9].”
BackgroundSelf-citationAhmad, E., Waller, H. L., Sargeant, J. A., Webb, M. A., Htike, Z. Z., McCann, G. P., Gulsin, G., Khunti, K., Yates, T., Henson, J., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14343 · Cited by 27
Metadata
- Authors
- Yaribeygi, H., Atkin, S. L., Pirro, M., & Sahebkar, A.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-11-11
- Volume
- 234
- Issue
- 6
- Pages
- 8286-8294
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2901351833
- Cited by
- 72
- References
- 22
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of the anti‐inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. https://app.cochat.ai/papers/10.1002/jcp.27699
- The paper
- Yaribeygi, H., Atkin, S. L., Pirro, M., & Sahebkar, A. (2019). A review of the anti‐inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.27699
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.